These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 31024507
1. Molecular Characterization and Antifungal Susceptibility of Clinical Fusarium Species From Brazil. Herkert PF, Al-Hatmi AMS, de Oliveira Salvador GL, Muro MD, Pinheiro RL, Nucci M, Queiroz-Telles F, de Hoog GS, Meis JF. Front Microbiol; 2019; 10():737. PubMed ID: 31024507 [Abstract] [Full Text] [Related]
5. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis. Todokoro D, Suzuki T, Tamura T, Makimura K, Yamaguchi H, Inagaki K, Akiyama H. Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866 [Abstract] [Full Text] [Related]
6. A 23 bp cyp51A Promoter Deletion Associated With Voriconazole Resistance in Clinical and Environmental Isolates of Neocosmospora keratoplastica. James JE, Lamping E, Santhanam J, Milne TJ, Abd Razak MF, Zakaria L, Cannon RD. Front Microbiol; 2020 Feb; 11():272. PubMed ID: 32296397 [Abstract] [Full Text] [Related]
7. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China. Song Y, Liu X, Yang Z, Meng X, Xue R, Yu J, Al-Hatmi AMS, de Hoog GS, Li R. Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979 [Abstract] [Full Text] [Related]
9. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India. Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, van Diepeningen AD. Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574 [Abstract] [Full Text] [Related]
10. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method. Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, Melhem TM, Pelaez T, Pfaller MA, Szeszs MW, Takahaschi JP, Tortorano AM, Wiederhold NP, Turnidge J. Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334 [Abstract] [Full Text] [Related]
16. Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis. Rosa PDD, Ramirez-Castrillon M, Borges R, Aquino V, Meneghello Fuentefria A, Zubaran Goldani L. J Med Microbiol; 2019 Oct 03; 68(10):1489-1496. PubMed ID: 31419209 [Abstract] [Full Text] [Related]
18. Airborne transmission of invasive fusariosis in patients with hematologic malignancies. Moretti ML, Busso-Lopes AF, Tararam CA, Moraes R, Muraosa Y, Mikami Y, Gonoi T, Taguchi H, Lyra L, Reichert-Lima F, Trabasso P, de Hoog GS, Al-Hatmi AMS, Schreiber AZ, Kamei K. PLoS One; 2018 Oct 03; 13(4):e0196426. PubMed ID: 29698435 [Abstract] [Full Text] [Related]
19. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China]. Sun S, Lyu Q, Han L, Ma Q, Hu H, He S, Tao S, Zhang J, Zhang H, Wang L. Zhonghua Yan Ke Za Zhi; 2015 Sep 03; 51(9):660-7. PubMed ID: 26693650 [Abstract] [Full Text] [Related]